TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24813167

Group type: EXPERIMENTAL
Intervention: Call group (nurses called out to the operator before approaching the patient)
Number of subjects: 93

Group type: COMPARATOR
Intervention: No-call group (nurses did not call out to the operator before approaching the patient)
Number of subjects: 93
Study: 22090168

Group type: EXPERIMENTAL
Intervention: Supervised exercise (SE)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Stent revascularization (ST)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Optimal medical care (OMC)
Number of subjects: 111
Study: 21034274

Group type: COMPARATOR
Intervention: Laparoscopic anti-reflux surgery (LARS) alone (group A)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Laparoscopic anti-reflux surgery (LARS) with concomitant cholecystectomy (group B)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Comparison of complications between group A and group B
Number of subjects: 1000
Study: 18336399

Group type: EXPERIMENTAL
Intervention: 12 cycles of single-agent paclitaxel (175 mg/m(2) over 3 h every 28 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Three cycles of the same treatment regimen (paclitaxel)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 12-cycle maintenance program with baseline CA-125 level <or=10 units/mL
Number of subjects: 0
Study: 16181163

Group type: EXPERIMENTAL
Intervention: Haloperidol 1.5 mg/d
Number of subjects: 430

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 430
Study: 12749512

Group type: EXPERIMENTAL
Intervention: Quetiapine (combined groups: 150, 300, 600, and 750 mg)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Haloperidol (12 mg)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 257
Study: 10556610

Group type: EXPERIMENTAL
Intervention: Neurological patients
Number of subjects: 4

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 4
Study: 8712391

Group type: EXPERIMENTAL
Intervention: Esmolol 1 mg/kg
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (standard succinylcholine/methohexital anesthetic)
Number of subjects: 13
Study: 1984710

Group type: EXPERIMENTAL
Intervention: Alprazolam 0.25 mg t.i.d. for 14 days
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Buspirone 5 mg t.i.d. for 14 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 29953951

Group type: EXPERIMENTAL
Intervention: Resistance before aerobic training (RA)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Aerobic before resistance training (AR)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 45
Study: 27977699

Group type: EXPERIMENTAL
Intervention: Moral emotions elicited in everyday social interactions
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Qualitative and quantitative methods
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Categorical systems based on participants' descriptions
Number of subjects: 312
Study: 25450242

Group type: EXPERIMENTAL
Intervention: Lensx femtosecond laser‐assisted cataract surgery capsulotomy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Lensar femtosecond laser‐assisted cataract surgery capsulotomy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Manual continuous curvilinear capsulorhexis
Number of subjects: 90
Study: 22984102

Group type: EXPERIMENTAL
Intervention: Early class III protraction facemask treatment (PFG)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control/no treatment group (CG)
Number of subjects: 73
Study: 20636227

Group type: EXPERIMENTAL
Intervention: Red Yeast Rice (RYR) - HypoCol, 4 capsules/day
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 18414905

Group type: EXPERIMENTAL
Intervention: Home-based physical activity program (12-week telephone counseling)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Contact control group
Number of subjects: 86
Study: 16984654

Group type: EXPERIMENTAL
Intervention: Zidovudine plus lamivudine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 14528656

Group type: EXPERIMENTAL
Intervention: H1‐receptor antagonist (0.1 mg/kg BW dimetindene) plus H2‐receptor antagonist (5 mg/kg BW cimetidine) diluted with 100 ml 0.9% NaCl
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (100 ml 0.9% NaCl)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: H1‐receptor antagonist plus H2‐receptor antagonist
Number of subjects: 17
Study: 10632409

Group type: EXPERIMENTAL
Intervention: Intracytoplasmic sperm injection
Number of subjects: 76

Group type: COMPARATOR
Intervention: IVF
Number of subjects: 76
Study: 9361539

Group type: EXPERIMENTAL
Intervention: Additional repeated colloid fluid challenges with oesophageal Doppler ultrasonography
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional intraoperative fluid management (control)
Number of subjects: 40
Study: 1490088

Group type: EXPERIMENTAL
Intervention: Carteolol eye drops
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Timolol eye drops
Number of subjects: 72

Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 72
Study: 3985778

Group type: EXPERIMENTAL
Intervention: Alternating air mattress
Number of subjects: 32

Group type: COMPARATOR
Intervention: Silicore mattress
Number of subjects: 32
Study: 30920646

Group type: EXPERIMENTAL
Intervention: Willingness to bear adversity (trading quality of life for survival)
Number of subjects: 524

Group type: EXPERIMENTAL
Intervention: Absolute certainty about curability (ACC)
Number of subjects: 524

Group type: COMPARATOR
Intervention: Willingness to bear treatment-related toxicities
Number of subjects: 524
Study: 29438157

Group type: EXPERIMENTAL
Intervention: Varenicline (2 mg/d)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Varenicline (2 mg/d) + Low-dose Naltrexone (25 mg/d)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 27070952

Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 148

Group type: COMPARATOR
Intervention: Control
Number of subjects: 148
Study: 24615211

Group type: EXPERIMENTAL
Intervention: Group A (Waiguan TE5 and Qiuxu GB40)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Group B (Neiguan PC6 and Taichong LR3)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 20
Study: 22546895

Group type: EXPERIMENTAL
Intervention: Intravenous buspirone (0.3 mg)
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: Intravenous buspirone (1.0 mg)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study: 21526663

Group type: COMPARATOR
Intervention: Supine position (group S)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Lateral position (group L)
Number of subjects: 120
Study: 18550874

Group type: EXPERIMENTAL
Intervention: 7.5 microg of hemagglutinin antigen without adjuvant
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: 15 microg of hemagglutinin antigen without adjuvant
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: 3.75 microg, 7.5 microg, 15 microg, or 30 microg of hemagglutinin antigen with alum adjuvant
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: All vaccine formulations
Number of subjects: 275
Study: 15821819

Group type: EXPERIMENTAL
Intervention: Intravenous dalteparin
Number of subjects: 20
Study: 12057022

Group type: EXPERIMENTAL
Intervention: Training workshops
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Barriers to completion of Cochrane reviews
Number of subjects: 179
Study: 9931171

Group type: EXPERIMENTAL
Intervention: 30 minutes of brisk walking 5 to 7 times weekly for 12 weeks
Number of subjects: 20
Study: 7752011

Group type: EXPERIMENTAL
Intervention: Vitamin A (100,000 IU for children <1 year, 200,000 IU for older children)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study: 2175139

Group type: EXPERIMENTAL
Intervention: Dexamethasone (2 or 4 mg in an iv bolus 10 min before insulin or smoking)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Insulin (0.15 IU/kg in an iv bolus)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cigarette smoking (2 non-filter cigarettes smoked in succession within 10 min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dexamethasone alone (2 or 4 mg in an iv bolus)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hypoglycemia
Number of subjects: 24
Study: 7017189

Group type: EXPERIMENTAL
Intervention: L-Keflex
Number of subjects: 215

Group type: COMPARATOR
Intervention: Keflex
Number of subjects: 215
Study: 31285062

Group type: EXPERIMENTAL
Intervention: Intervention group (n=20)
Number of subjects: 40
Study: 28390794

Group type: EXPERIMENTAL
Intervention: First view on the postbiopsy mammogram obtained in the same projection as that used during the biopsy procedure (group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: First view on the postbiopsy mammogram obtained orthogonally to the projection used during the biopsy procedure (group 2)
Number of subjects: 60
Study: 26180356

Group type: EXPERIMENTAL
Intervention: Elastic band resistance exercise program (3 times per week for five months)
Number of subjects: 23
Study: 23477995

Group type: EXPERIMENTAL
Intervention: Standardized physical examination alone
Number of subjects: 15239

Group type: COMPARATOR
Intervention: Laboratory tests plus standardized physical examination
Number of subjects: 15239
Study: 21680993

Group type: EXPERIMENTAL
Intervention: OneTouch® Delica™
Number of subjects: 200

Group type: COMPARATOR
Intervention: OneTouch® Comfort™
Number of subjects: 200

Group type: COMPARATOR
Intervention: ACCU‐CHEK® Softclix
Number of subjects: 200

Group type: COMPARATOR
Intervention: ACCU‐CHEK® Multiclix
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ascensia® Microlet™2
Number of subjects: 200
Study: 18602635

Group type: EXPERIMENTAL
Intervention: Caloric restriction (CR) - 25% calorie restriction
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Caloric restriction with exercise (CR+EX) - 12.5% CR + 12.5% increase in energy expenditure via aerobic exercise
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control - 100% of energy requirements
Number of subjects: 36
Study: 16673799

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate 0.05% shampoo, treated once daily for 4 weeks, rinsed off after 15 minutes
Number of subjects: 26

Group type: COMPARATOR
Intervention: Clobetasol propionate gel, leave-on formulation
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate shampoo and gel
Number of subjects: 26
Study: 12823492

Group type: EXPERIMENTAL
Intervention: Pramipexole (PPX; Mirapexin)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Pergolide (PRG; Permax)
Number of subjects: 41
Study: 10814600

Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8634406

Group type: EXPERIMENTAL
Intervention: Meglumine-sodium-ioxaglate (Hexabrix)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Iopromide (Ultravist)
Number of subjects: 60
Study: 1643675

Group type: EXPERIMENTAL
Intervention: Intraoperative iv clonidine (Group 1)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Balanced anaesthesia alone (Group 2)
Number of subjects: 200
Study: 6608858

Group type: EXPERIMENTAL
Intervention: 17 alpha‐hydroxyprogesterone caproate for one year
Number of subjects: 22

Group type: COMPARATOR
Intervention: No further treatment
Number of subjects: 22
Study: 30484269

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) dosed at bedtime
Number of subjects: 175

Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) dosed in the morning
Number of subjects: 175
Study: 29796596

Group type: EXPERIMENTAL
Intervention: Electronic music improvisation with a music therapist (MT)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Recorded music listening (ML)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 60
Study: 26802087

Group type: EXPERIMENTAL
Intervention: AVX-470 at 3.5g/day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 24474305

Group type: EXPERIMENTAL
Intervention: 12 weeks of telephone cessation counseling
Number of subjects: 214

Group type: COMPARATOR
Intervention: U.S. Public Health Service Clinical Practice Guideline information
Number of subjects: 214
Study: 22155457

Group type: EXPERIMENTAL
Intervention: Exenatide (10 μg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Glibenclamide (5 mg)
Number of subjects: 20
Study: 20082585

Group type: EXPERIMENTAL
Intervention: Technosphere inhaled insulin
Number of subjects: 119

Group type: COMPARATOR
Intervention: Inhaled placebo
Number of subjects: 119
Study: 17640310

Group type: EXPERIMENTAL
Intervention: Oral valganciclovir (900 mg daily for 21 days, then 900 mg daily for 28 days)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Intravenous ganciclovir (5 mg/kg twice daily for 21 days)
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 321
Study: 15911902

Group type: EXPERIMENTAL
Intervention: Verapamil SR strategy
Number of subjects: 2317

Group type: COMPARATOR
Intervention: Atenolol strategy
Number of subjects: 2317
Study: 12409329

Group type: EXPERIMENTAL
Intervention: Granulocyte-macrophage colony-stimulating factor (GM-CSF) 250 micro g
Number of subjects: 133

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study: 10089184

Group type: COMPARATOR
Intervention: D1 lymph-node dissection
Number of subjects: 996

Group type: EXPERIMENTAL
Intervention: D2 lymph-node dissection
Number of subjects: 996
Study: 7478041

Group type: EXPERIMENTAL
Intervention: MIBI-dipy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ECHO-dipy
Number of subjects: 60
Study: 1975746

Group type: EXPERIMENTAL
Intervention: Thymostimulin (TP1)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 114127

Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 1332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1332
Study: 31987116

Group type: EXPERIMENTAL
Intervention: Low energy diet containing 50 g of Kashk (intervention group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Low energy diet without Kashk (control group)
Number of subjects: 70
Study: 30367257

Group type: EXPERIMENTAL
Intervention: Calcium hydroxide-based intracanal medication (ICM) after 30 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2% chlorhexidine (CHX) gel
Number of subjects: 20

Group type: COMPARATOR
Intervention: 6% sodium hypochlorite (NaOCl)
Number of subjects: 20
Study: 28891855

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 600

Group type: COMPARATOR
Intervention: Fentanyl/midazolam
Number of subjects: 600
Study: 26421166

Group type: EXPERIMENTAL
Intervention: Oxybutynin
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Desmopressin
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 92
Study: 23405158

Group type: EXPERIMENTAL
Intervention: sTNFR1 at 24 hours
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Relative increases in sTNFR1 and sTNFR2 over 24 hours
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: sTNFRs
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Soluble Fas and sFasL
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Apoptosis markers
Number of subjects: 48
Study: 21941411

Group type: EXPERIMENTAL
Intervention: DHA 400 mg/day from 12th week gestation until 4 months postpartum
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 19678875

Group type: EXPERIMENTAL
Intervention: Goal fantasies focusing on motive-specific affective incentives
Number of subjects: 273

Group type: COMPARATOR
Intervention: Hypothetical goal selection
Number of subjects: 273

Group type: EXPERIMENTAL
Intervention: Commitment to personal goals
Number of subjects: 273
Study: 16858634

Group type: EXPERIMENTAL
Intervention: 15-session HIV and trauma coping group intervention
Number of subjects: 202

Group type: COMPARATOR
Intervention: 15-session support group comparison condition
Number of subjects: 202

Group type: COMPARATOR
Intervention: waitlist control
Number of subjects: 202
Study: 15385901

Group type: EXPERIMENTAL
Intervention: WiLLOW intervention
Number of subjects: 366
Study: 11133605

Group type: EXPERIMENTAL
Intervention: Remifentanil infusions
Number of subjects: 100

Group type: COMPARATOR
Intervention: Meperidine boluses
Number of subjects: 100
Study: 9644229

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg, n=6; 100 mg, n=2; 120 mg, n=1)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Metoprolol (100 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 7831416

Group type: EXPERIMENTAL
Intervention: Five syndrome model based on factor analysis
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Positive and Negative Syndrome Scale (PANSS)
Number of subjects: 240
Study: 2757891

Group type: EXPERIMENTAL
Intervention: Digoxin (inhibitor of the sodium/potassium pump)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dipyridamole (inhibitor of the anion transporter)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lithium carbonate (oral load)
Number of subjects: 0
Study: 1023958

Group type: EXPERIMENTAL
Intervention: Suxamethonium and endotracheal intubation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no pancuronium)
Number of subjects: 20
Study: 31768805

Group type: EXPERIMENTAL
Intervention: Semantic relatedness in productive test
Number of subjects: 0

Group type: COMPARATOR
Intervention: Semantic unrelated items in receptive test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantic relatedness in Experiment 2
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Semantic relatedness in language input
Number of subjects: 0
Study: 30421856

Group type: COMPARATOR
Intervention: IBT (IBT‐alone)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: IBT combined with liraglutide (IBT‐liraglutide)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: IBT‐liraglutide combined with meal replacements (Multicomponent)
Number of subjects: 150
Study: 28627349

Group type: EXPERIMENTAL
Intervention: Abdominal lifting and compression CPR
Number of subjects: 66

Group type: COMPARATOR
Intervention: Unarmed abdominal compression CPR
Number of subjects: 66
Study: 26107215

Group type: EXPERIMENTAL
Intervention: Lobaplatin 50mg/m2, MMC 16mg/m2, Vincristine 2mg/m2 every 21 days (Group A)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Cisplatin 100mg/m2, MMC 16mg/m2, Vincristine 2mg/m2 every 21 days (Group B)
Number of subjects: 86
Study: 23499390

Group type: EXPERIMENTAL
Intervention: Enobosarm 1 mg
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Enobosarm 3 mg
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 21448267

Group type: EXPERIMENTAL
Intervention: Verum acupuncture (n=99 provided data)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Sham acupuncture (n=101 provided data)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Standard care (n=62 provided data)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Acupuncture cohort (verum and sham combined)
Number of subjects: 277
Study: 19553295

Group type: EXPERIMENTAL
Intervention: Lysine ingestion (1 mmol lysine/kg lean body mass)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Lysine plus glucose (25 g glucose)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Lysine ingestion
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Lysine plus glucose
Number of subjects: 13

Group type: COMPARATOR
Intervention: Glucose ingestion
Number of subjects: 13
Study: 22222469

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: N-terminal pro-brain natriuretic peptide
Number of subjects: 55
Study: 15987985

Group type: EXPERIMENTAL
Intervention: Gamma brachytherapy with an iridium 192 source (14-Gy dose at 2 mm into the arterial wall)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Stent implantation only
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Stent and brachytherapy group
Number of subjects: 88
Study: 12583947

Group type: EXPERIMENTAL
Intervention: Fish oil capsules (n-3 PUFAs)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Sunflower oil capsules (n-6 PUFAs)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 188
Study: 10808387

Group type: EXPERIMENTAL
Intervention: BAL from segment A (s.A)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: BAL from segment B (s.B)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Peripheral blood
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 28
Study: 7484831

Group type: EXPERIMENTAL
Intervention: Internal atrial defibrillation using biphasic shocks with the right atrium (RA) and left pulmonary artery or coronary sinus (CS) configuration.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Right ventricle (RV) and superior vena cava configuration.
Number of subjects: 18

Group type: COMPARATOR
Intervention: RA and axilla configuration.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: RV to RA configuration.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: RA-left pulmonary artery/CS configuration.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Biphasic shocks delivered without anesthesia.
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Shocks > or = 3 J.
Number of subjects: 18
Study: 2110954

Group type: EXPERIMENTAL
Intervention: Midazolam 0.25 mg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Midazolam 0.35 mg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Midazolam 0.45 mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 80
Study: 394555

Group type: EXPERIMENTAL
Intervention: Hyperbaric 5% lidocaine with 75 mg/ml glucose concentration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyperbaric 5% lidocaine with 50 mg/ml glucose concentration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of both hyperbaric 5% lidocaine solutions
Number of subjects: 0
Study: 11841067

Group type: EXPERIMENTAL
Intervention: Biocompatible membrane (BCM, polysulfone)
Number of subjects: 41